GSK investigating whether Shingles vaccine reduces dementia risk

Signage is pictured in the main lobby of GSK offices in London, Britain, February 20, 2025. — Reuters LONDON: GSK on Tuesday said that it is studying a group of more than a million older adults in the UK to conclude if its best-selling shingles vaccine lowers the risk of...

from The News International - Health https://ift.tt/a3qfOPR